4 Healthcare Stock Stories for Monday Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Cytokinetics, Incorporated (NASDAQ:CYTK): Current price $1.07

On Thursday, the firm received a notice from Nasdaq confirming that for the last 10 consecutive business days, the closing bid price of the Company’s common stock has been at $1 per share or higher, and thus the firm has regained compliance with Listing Rule 5450a(1). On June 18, 2012. the company’s common stock had failed to maintain the minimum bid price over the previous 30 consecutive business days, as required by the Listing Rules of the Nasdaq Stock Market.

Picture 236

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business